Aman's Global Market Intelligence

1 · Executive dashboard

Strong trend · elevated energy/duration risk

Regime call: neutral/selective risk-on. Friday left the S&P close to Thursday's record, VIX at 14.25 and small caps positive, but the official 10-year yield rebounded to 4.68%, WTI finished at $82.40 and weekend Iran/SPR headlines keep an inflation shock in play. AI demand evidence remains powerful; financing opacity and extreme expectations argue for confirmation rather than Monday gap-chasing.

S&P 5007,785.76−0.17% Fri

Nasdaq26,729.16−0.28%

Dow53,732.41−0.20%

Russell 20003,068.42+0.51%

VIX14.25−2.60% vol

U.S. 2Y4.17%official Aug. 14

U.S. 10Y4.68%official Aug. 14

Dollar index99.67−0.29%

WTI future$82.40+1.42%

Gold future$4,437.30+1.69%

Market	Last close / move	Sunday read-through
Nikkei 225	68,713.80 · +0.59%	Friday close; Japan momentum constructive, but no Sunday cash signal.
Hang Seng	25,116.85 · −1.10%	China/HK breadth lagged.
Shanghai Composite	3,927.18 · +0.01%	Flat mainland close.
Euro Stoxx 50	6,539.59 · −0.09%	Near-flat European risk appetite.
DAX	26,440.31 · +0.53%	Friday European outperformer.
FTSE 100	10,750.10 · −0.21%	Oil support did not lift the broad index.
S&P / Nasdaq futures	ES 7,805.00 / NQ 30,141.75	Friday settlements (−0.22% / −0.15%), not live Sunday pricing.

1 · Energy tail risk intensified

EIA put SPR stocks at 298.694M barrels for Aug. 7, down 6.115M w/w. CNBC reported operational/cavern concerns amid the Iran-related drawdown, while also carrying the Energy Department's rebuttal to collapse claims. The investable point is reduced emergency cushion and upside oil-volatility risk—not certainty of damage.

2 · Major AI ownership disclosures

NVIDIA's Aug. 14 13F reported eight holdings worth $63.44B at June 30; Intel alone was $29.99B. CNBC calculated the SpaceX stake at about $21B quarter-end and about $17.2B at Friday's close. This adds asset-value support and cross-holding volatility.

3 · Berkshire validates Alphabet—late

Berkshire's primary 13F table totals 105,979,600 Alphabet A/C shares at June 30. CNBC says 48.1M shares were added in Q2. This is quality validation, but it is a lagged filing—not a Monday buy signal.

2 · Market drivers and coming-week setup

08:30 Italy precedes most U.S. releases

Macro, rates and central banks

Treasury: 2Y 4.17%, 10Y 4.68%, 30Y 5.25% on Aug. 14; the +51 bp 2s10s curve and 5%+ long bond keep duration-sensitive valuation exposed.
Last week's CPI/PPI moderation supported equities, but July retail sales and Michigan sentiment weakened. The tension is slower demand versus still-high inflation expectations.
FOMC minutes from July 28–29 arrive Wednesday Aug. 19 at 14:00 ET; industrial production is Tuesday at 09:15 ET.
Confirmation: 10Y below 4.60% with stable oil. Risk-off trigger: 10Y above 4.80% and WTI above $85 together.

Geopolitics, earnings, regulation and rotation

Hormuz/shipping headlines and a smaller SPR cushion make oil the fastest macro transmission channel into yields, transport margins and consumer confidence.
Retailers Home Depot, Target, Lowe's and Walmart test whether July sales weakness was timing-related or broad. Company timing should be rechecked immediately before trading.
AI rotation is not monolithic: Friday VRT +2.36% and quantum names rose, while ANET −2.36%, CRDO −2.29%, LLY −2.39% and NVO −1.78%.
CNBC reports increasingly complex AI funding via bonds, leases and private vehicles; this supports deployment but can hide leverage and future liquidity needs. Favor balance-sheet visibility.

3 · Theme dashboards

AI / semis / cloud Demand strong · funding risk rising

Friday relative leader: VRT $293.84 (+2.36%). Laggards: ANET $198.82 (−2.36%), CRDO $259.90 (−2.29%). NVDA $225.16 (−0.06%).
NVIDIA's holdings disclosure adds Intel/SpaceX mark-to-market exposure; Berkshire's filing adds an Alphabet sentiment catalyst.
CNBC reported Anthropic Q2 revenue above $11.5B, but this is a media report about a private company—not audited public-company evidence.
Valuation/speculation risks: capex returns, lease/off-balance-sheet commitments, customer concentration, power/cooling constraints, export controls and earnings hurdles.

Quantum Venture-like public equities

Friday: IONQ $46.26 (+2.85%), QBTS $21.17 (+1.29%), RGTI $18.82 (+1.07%), QUBT $9.01 (+1.01%). Positive tape, but no fresh weekend primary milestone was verified.
The latest previously verified IonQ quarter showed $80.05M revenue, $120.3M adjusted EBITDA loss and $254.8M six-month operating cash use; Sep. 8 Investor Day is the focused gate.
Risks: technical roadmap slippage, acquisitions/integration, stock compensation, dilution/warrants, contract lumpiness and extreme volatility. QUBT is a sub-$10 speculative small cap; price alone does not make it cheap.

Peptide / metabolic biotech Quality leaders vs binary small cap

Friday: LLY $1,180.16 (−2.39%), NVO $45.89 (−1.78%), VKTX $33.19 (+0.76%).
Viking: Phase 3 VANQUISH-1/2 are fully enrolled; randomized, double-blind, placebo-controlled trials run 78 weeks, with percent body-weight change primary and ≥5/10/15/20% responder measures secondary/exploratory. Q3 maintenance data and 4Q oral Phase 3 initiation are planned.
Phase 2 VENTURE reached up to 14.7% mean weight reduction after 13 weekly doses; most treatment-emergent adverse events were mild/moderate, per the company. Phase 3 duration, discontinuations and safety remain decisive.
VKTX had $502M quarter-end cash; its 116.65M shares outstanding rose from 114.79M at year-end. Competition, dilution and binary data exposure remain high.

4 · Ranked ideas

Conditional paper setups · no forced trades

#1 NVDA · NVIDIA Conditional bullish

Nasdaq · mega-cap AI compute/networking · premium valuation / export / earnings-gap risk

Day trade: only after Monday breadth1–4 weeks: applicable, event-sized3–12+ months: applicable, staggered

Direction / thesis / catalyst: uncertain positive. Friday held the $224 breakout area; Aug. 26 results are the decisive gate. New 13F asset values and SpaceX's reported exclusive NVIDIA use support ecosystem breadth.

Evidence / counterargument: SEC 13F: $63.44B of holdings, including $29.99B Intel at June 30. Counter: cross-holdings add mark-to-market volatility; financing complexity, China limits and extreme earnings expectations can compress the multiple.

Entry / confirmation: hold $224 after the first hour, or a controlled $220–224 retest/reclaim with SOXX and data-center peers participating. Do not buy solely on a weekend headline.

Invalidation / downside: close below $216; material earnings/order miss; adverse export rule; or multiple AI leaders losing post-result support. A gap through invalidation can exceed the planned loss.

Key risks: Aug. 26 gap, valuation, customer/financing concentration, HBM/power supply, competition, export policy.

Confidence

Risk

Opportunity

#2 CBRS · Cerebras Systems Avoid / no short claim

Nasdaq · newly public high-risk AI semiconductor/cloud · price-discovery and squeeze risk

Day trade: unsuitable for most1–4 weeks: avoid until base3–12+ months: milestone watch

Direction / thesis / catalyst: uncertain bearish/avoid. Friday's $218.98 close (−5.21%) extended post-results price discovery; no new weekend primary fact repairs the chart.

Evidence / counterargument: Friday volume and selloff validated caution. Counter: raised guidance, cloud growth and reported liquidity can generate a violent reversal—hence avoid, not a short recommendation.

Entry / confirmation: no entry. Upgrade only after several sessions holding $215–220, a reclaim of $231 and evidence of repeatable margin execution.

Invalidation / downside: avoid stance invalidates on a durable base and execution beats; downside risk worsens below Friday's $215.78 low.

Key risks: limited public history, customer concentration, manufacturing scale, margins, dilution and squeeze. No borrow availability/fee claim.

Confidence

Risk

Opportunity

#3 CRWV · CoreWeave Avoid chase · not a short

Nasdaq · high-risk AI cloud · leverage / capex / concentration / squeeze risk

Day trade: only defined-risk1–4 weeks: wait for base3–12+ months: financing watch

Direction / thesis / catalyst: uncertain bearish/avoid. Friday $105.26 held $100, but the broader weekend focus on opaque AI leverage reinforces the demand-versus-capital-structure split.

Evidence / counterargument: Q2 SEC exhibit previously showed $2.575B revenue, ~$104B backlog, $626M net loss and $640M net interest expense. Counter: $1.51B adjusted EBITDA and contracted power can produce operating leverage.

Entry / confirmation: no chase. Require a stable base over $100, funded capex, lower interest burden and credible free-cash conversion.

Invalidation / downside: avoid stance changes with durable positive free cash flow and balance-sheet improvement; downside worsens on a close below $100.

Key risks: refinancing, dilution, customer concentration, utilization, power delivery, GPU supply and squeeze. No borrow representation.

Confidence

Risk

Opportunity

Watchlist · five maximum

GOOGL · Alphabet Quality / weekend 13F catalyst

Nasdaq · mega-cap cloud/AI · horizons: day/swing/long, but no gap chase · C/R/O 90/60/66. Friday $345.90 (−0.13%). Thesis: Berkshire's 105.98M-share June holding validates quality. Counter: filing is 45 days stale and capex/regulatory risk remains. Confirmation: hold above Friday close after any gap, then a volume-backed new high. Invalidation: fill/reject the catalyst gap plus relative underperformance. Risks: antitrust, AI search substitution, capex and valuation.

VRT · Vertiv Power/cooling momentum

NYSE · large-cap data-center infrastructure · horizons: day/swing/long · C/R/O 76/82/62. Friday $293.84 (+2.36%). Thesis: relative strength in a weak data-center networking tape. Counter: high AI-beta and capex-cycle expectations. Confirm only on a pullback holding $287 or a volume-backed break above Friday high; invalidate on a close below $280. Risks: valuation, customer timing, supply chain and crowded positioning.

LLY · Eli Lilly Commercial leader / technical repair needed

NYSE · mega-cap peptide leader · horizons: swing/long, not Monday day setup · C/R/O 85/70/51. Friday $1,180.16 (−2.39%). Thesis: commercial scale and pipeline quality; counter: failed $1,200–1,220 area, valuation, access and competition. Confirmation: reclaim and hold $1,200, then $1,220. Invalidation: new closing low with estimate cuts. Risks: safety, manufacturing, reimbursement, competition and pipeline events.

IONQ · IonQ Extreme-risk quantum

NYSE · speculative quantum · horizons: day only for specialists; swing into Sep. 8; long venture-sized · C/R/O 78/96/48. Friday $46.26 (+2.85%). Thesis: revenue growth and Investor Day catalyst. Counter: heavy adjusted loss, cash use, acquisitions and stock compensation. Confirm with a stable multi-day base and specific independently verified roadmap milestones; invalidate on failed breakout/new base low. Risks: dilution, integration, technical slippage, contract lumpiness and extreme volatility.

VKTX · Viking Therapeutics Small-cap binary biotech

Nasdaq · small-cap clinical biotech · horizons: catalyst swing/venture long only; not routine day trade · C/R/O 80/97/58. Friday $33.19 (+0.76%). Thesis: fully enrolled Phase 3 program, Q3 maintenance data and $502M cash. Counter: maintenance readout may not predict 78-week Phase 3 success; share count rose. Confirm only with disclosed protocol, estimand/statistics, completion/dropout and safety detail. Invalidate on clinically weak maintenance, safety imbalance, delay or cash-runway deterioration. Risks: binary data, GI tolerability, competition, regulatory path and dilution.

5 · Changes versus Aug. 15

Weekend facts only · no price hindsight

Item	Yesterday	Today's change	Action
Regime	Neutral/selective risk-on	Unchanged; no new cash session.	Wait for Sunday futures/Monday breadth.
NVDA	#1 conditional bullish	13F confirms $63.44B equity portfolio; SpaceX/Intel marks add asset support and volatility.	Retain; confidence +1, risk +2 into earnings.
Alphabet	Not active	Berkshire 13F confirms 105.98M A/C shares at June 30.	Add to watchlist; explicitly avoid headline gap chase.
Oil / macro	WTI/geopolitical risk	EIA verifies SPR below 300M barrels; weekend operational debate intensifies.	Elevate oil/yield joint trigger.
CBRS / CRWV	Avoid / no short	No verified primary repair; AI leverage scrutiny persists.	Retain avoid classifications.
Quantum / peptide	IONQ and VKTX watch	No fresh weekend primary milestone found.	Keep catalyst-only sizing and confirmation rules.

6 · Important 7–30 day catalysts

ET unless stated · reverify before execution

Mon Aug. 17 · 08:30 — Empire State manufacturing

First activity check; 08:30 Italy report publication precedes it.

Tue Aug. 18 · 08:30 / 09:15 / 10:00 — Import/export prices; industrial production; housing starts/permits

Inflation, factories and construction. Fed confirms industrial production at 09:15 ET.

Aug. 18–20 — Home Depot, Target, Lowe's, Walmart, Alibaba

Consumer, housing, China-commerce and cloud read-through; verify each IR page.

Wed Aug. 19 · 10:30 — EIA petroleum status

Next official SPR/commercial inventory checkpoint. EIA schedule.

Wed Aug. 19 · 14:00 — July 28–29 FOMC minutes

Policy reaction function and inflation-risk debate. Federal Reserve.

Wed Aug. 26 — GDP/PCE/durables; NVIDIA after close

Largest combined rates-and-AI valuation gate; earnings timing should be rechecked on NVIDIA IR.

Q3 2026 — Viking VK2735 maintenance-dosing data

Need protocol, dosing, weight regain/maintenance, estimand, completion, adverse events and discontinuations—not only headline efficacy.

Tue Sep. 8 — IonQ Investor Day

Demand specific technical, bookings-to-revenue, cash-use and integration milestones.

Tue Sep. 15–Wed Sep. 16 — FOMC meeting

30-day boundary and major rates catalyst; oil/inflation path will matter.

7 · Bottom line by horizon

Day trade · Monday

Do not trade weekend headlines in isolation. Let futures reopen, then require the first-hour cash tape. Preferred conditional setup: NVDA holds $224 with broad semis; GOOGL must hold any Berkshire-related gap. Avoid CBRS/CRWV volatility unless risk is explicitly capped.

1–4 week swing

NVDA is the only ranked conditional long and must be sized for Aug. 26. GOOGL and VRT need confirmation. LLY needs technical repair. IONQ/VKTX are event-risk positions, not ordinary swings.

3–12+ month investment

Favor cash-generative AI/platform and commercial peptide leaders over leveraged clouds, newly public price discovery and pre-profit quantum. Stagger entries because 4.68% 10Y yields and oil shocks can compress even high-quality multiples.

Biggest risk: Hormuz disruption plus a constrained SPR keeps WTI above $85, lifts long yields and meets weakening consumer demand—stagflationary multiple compression. Risk-on validation: WTI below $80, 10Y below 4.60%, VIX below 15 and broad AI participation. Regime invalidation: 10Y above 4.80%, WTI above $85, VIX above 17 or the S&P losing its prior breakout with worsening breadth.

Sources & data quality

Data-quality panel

Local date/time was generated live with TZ=Europe/Rome date: Sunday 2026-08-16, 08:31 CEST.
Yahoo exchange-fed chart API succeeded for U.S./global indices, futures, commodities and 16 focused stocks; prices are Aug. 14 closes/settlements. Treasury official XML confirms 2Y 4.17%, 10Y 4.68%, 30Y 5.25% for Aug. 14.
Cash markets were closed at cutoff. No credible live Sunday futures indication was available before normal reopening; Friday futures settlements are explicitly labeled and no weekend quote is fabricated.
SEC EDGAR primary filings verify NVIDIA's 13F total and Intel holding, and Berkshire's Alphabet share counts. CNBC provides context/calculations for SpaceX and Berkshire additions; those figures are labeled as reporting, not primary company guidance.
EIA official CSV verifies SPR 298.694M barrels for Aug. 7 and next release Aug. 19. CNBC's cavern-risk story presents expert concern and the Energy Department's rebuttal.
Reuters browser retrieval hit a DataDome CAPTCHA. The report retried with accessible CNBC, SEC, Treasury, Fed, EIA, Viking IR and Yahoo sources; no fact depends solely on the blocked Reuters page.
IonQ IR was blocked by network resolution in this run; no fresh IonQ primary claim was added. ClinicalTrials.gov query returned no relevant records under the attempted filter, so Viking's official detailed trial release was used instead. BLS calendar returned HTTP 403; Fed/EIA official calendars and previously verified company IR dates cover cited events.
Confidence scores measure evidence quality—not probability of profit. Technical levels are conditional decision markers, not guarantees.